Silo Pharma’s SPU-21 Peptide Shows Positive Results Against Rheumatoid Arthritis
16 oct. 2023 08h11 HE
|
Silo Pharma, Inc.
Human tissue study assessed SPU-21’s efficiency, optimization, and binding affinity ENGLEWOOD CLIFFS, NJ, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a...
UMB Partners with Bottomline Technologies to Offer New Payables Solution
20 févr. 2019 09h00 HE
|
Bottomline Technologies, Inc.
PORTSMOUTH, N.H., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Bottomline Technologies (NASDAQ: EPAY), a leading provider of financial technology that helps make business payments simple, smart and secure, and...